NYSE:ALR - Alere Stock Price, Forecast & News Notice: This company has been marked as potentially delisted and may not be actively trading. Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Alere Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $2.15 0.00 (0.00 %) (As of 06/7/2019) Add Today's Range$2.15Now: $2.15▼$2.2250-Day Range N/A52-Week Range$34.41Now: $2.15▼$51.00Volume66,463 shsAverage Volume1.53 million shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Alere Inc is a provider of health information through diagnostic tests. The Company's segments include professional diagnostics, consumer diagnostics, and corporate and other. The professional diagnostics segment includes an array of diagnostic test products and other in vitro diagnostic tests marketed to medical professionals and laboratories for detection of diseases and conditions within its areas of focus. Read More… Industry, Sector and Symbol Stock Exchange NYSE Industry N/A Sub-IndustryHealth Care Supplies SectorN/A Current SymbolNYSE:ALR Previous Symbol CUSIP01449J10 CIK1145460 Webhttp://www.alere.com/ Phone+1-781-6473900Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableOptionable Receive ALR News and Ratings via Email Sign-up to receive the latest news and ratings for ALR and its competitors with MarketBeat's FREE daily newsletter. Alere (NYSE:ALR) Frequently Asked Questions What is Alere's stock symbol? Alere trades on the New York Stock Exchange (NYSE) under the ticker symbol "ALR." How were Alere's earnings last quarter? Alere Inc (NYSE:ALR) released its quarterly earnings data on Friday, November, 4th. The medical research company reported $0.19 EPS for the quarter, missing the Thomson Reuters' consensus estimate of $0.54 by $0.35. The medical research company earned $582 million during the quarter, compared to analysts' expectations of $605.50 million. The firm's quarterly revenue was down 3.6% on a year-over-year basis. During the same period last year, the company posted ($0.10) EPS. View Alere's Earnings History. Has Alere been receiving favorable news coverage? Headlines about ALR stock have trended somewhat negative this week, InfoTrie Sentiment reports. The research firm identifies positive and negative media coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Alere earned a news sentiment score of -1.7 on InfoTrie's scale. They also gave media stories about the medical research company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. View News Stories for Alere. Who are some of Alere's key competitors? Some companies that are related to Alere include Align Technology (ALGN), Cooper Companies (COO), DENTSPLY SIRONA (XRAY), West Pharmaceutical Services (WST), Haemonetics (HAE), ICU Medical (ICUI), Neogen (NEOG), Quidel (QDEL), STAAR Surgical (STAA), Merit Medical Systems (MMSI), Atrion (ATRI), Anika Therapeutics (ANIK), Antares Pharma (ATRS), Cerus (CERS) and OraSure Technologies (OSUR). What other stocks do shareholders of Alere own? Based on aggregate information from My MarketBeat watchlists, some companies that other Alere investors own include Morgan Stanley (MS), BioTelemetry (BEAT), FireEye (FEYE), Abbott Laboratories (ABT), Chembio Diagnostics (CEMI), Mantech International (MANT), Tivity Health (TVTY), Allergan (AGN), Anthem (ANTM) and E I Du Pont De Nemours And Co (DD). Who are Alere's key executives? Alere's management team includes the folowing people: Gregg J. Powers, Independent Chairman of the BoardNamal Nawana, President, Chief Executive Officer, DirectorJames F. Hinrichs, Chief Financial Officer, Executive Vice PresidentDaniella Cramp, Global President - Cardiometabolic Business UnitSanjay Malkani, Global President - ToxicologyAvi Pelossof, Global President - Infectious Disease Business UnitEllen Chiniara J.D., Senior Vice President, General Counsel, Chief Ethics and Compliance Officer, SecretaryRobert Hargadon, Senior Vice President - Global Human ResourcesJohn Bridgen Ph.D., Senior Vice President - Business DevelopmentMark Gladwell, Senior Vice President - Global Operations What is Alere's stock price today? One share of ALR stock can currently be purchased for approximately $2.15. What is Alere's official website? The official website for Alere is http://www.alere.com/. How can I contact Alere? Alere's mailing address is 51 Sawyer Rd Ste 200, WALTHAM, MA 02453-3448, United States. The medical research company can be reached via phone at +1-781-6473900. MarketBeat Community Rating for Alere (NYSE ALR)Community Ranking: 2.4 out of 5 ( )Outperform Votes: 400 (Vote Outperform)Underperform Votes: 423 (Vote Underperform)Total Votes: 823MarketBeat's community ratings are surveys of what our community members think about Alere and other stocks. Vote "Outperform" if you believe ALR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ALR will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 12/11/2019 by MarketBeat.com StaffFeatured Article: Put Option Volume
